Clinical Trials
4 trialsNCT03785964 2025-01-31
DeFi
SpringWorks Therapeutics, Inc.
Phase 3 Completed
NCT02066181 2023-06-07
Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
National Cancer Institute (NCI)
Phase 3 Completed
NCT05561036 2022-09-30
A Randomized, Double-blind,Phase â…¢ Study of Liposome Doxorubicin in Desmoid Tumor
Sun Yat-sen University
Phase 3 Unknown
NCT00538850 2014-03-05
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
Phase 3 Completed